19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is AGALSIDASE BETA, with a corresponding application number 2248966 and regulatory information .
proudly manufactured in the
Sanofi's FABRAZYME POWDER FOR SOLUTION, medication with 35MG/VIAL of AGALSIDASE BETA.